Myovant Sciences Ltd

:MYOV 4:00:00 PM EDT

26.98

-0.01 (-0.04%)

0:00:00 AM EDT: $26.98 0.00 (0.00%)

Products

FDA Approves First Oral Hormone Therapy For Treating Advanced Prostate Cancer

Published: 12/18/2020 17:34 GMT

MYOV

Myovant Sciences Ltd (MYOV) - FDA Approves First Oral Hormone Therapy for Treating Advanced Prostate Cancer.
FDA Approved Orgovyx (relugolix) for the Treatment of Adult Patients With Advanced Prostate Cancer.